Published by Nicolas Tierney
June 27, 2019
Use inCytes™ For Real-World Data Collection, Post-Market Data Reports and Other Requirements.
Two objectives shared by pharmaceutical and medical device companies are (a) the development of objective data substantiating the safety and efficacy of their products, and (b) earning the attention of busy healthcare professionals. inCytes™ provides several cost-efficient approaches to achieve both goals.
The inCytes™ modular framework begins at a granular level, enabling industry participants to design desired Observational Queries, specify user-submitted values for those Queries, assign Queries to topic-specific surveys ensuring clinically-efficient response collection and arrange those topics along a logical longitudinal clinical path. The resultant Observational Protocol captures verifiable, correlatable and relevant data pre-, peri- and post-procedurally, allowing even the smallest datum to have broad contextual value. The inCytes™ platform can be deployed in any language, with any measurement system, without losing the canonical value of resulting data from similar Observational Queries or their Responses.
Industry-sponsored Observational Protocols can easily be uploaded to inCytes™ Users accounts for immediate case fulfillment. New users can be provided complimentary versions of the software by the Sponsor.
All resulting aggregated, de-identified data is then available in a HIPAA/GDPR compliant manner from the cloud. Sponsors, as well as their Investigators, can navigate through a variety of customized reporting features.
Illustrative use cases for industry include:
The value of inCytes™ goes well beyond its clinically-powerful functionality. In addition to their own KOL’s, Sponsors have access to leading scientists, HCP’s and Affiliates of the global Regen Med Network.
April 12, 2023
Practitioners are increasingly being asked, instructed and/or incentivized to join data registries. These collaborative solutions allow practitioners to capture, aggregate and correlate unique real-world data not native to their EMR/EHR systems, including patient-reported outcomes. There is no shortage of solutions, many with dizzying levels of features, integrations, pricing models and clinical specializations.
April 3, 2023
It has been our pleasure to know and work with Jimmy Sung, MD, JD, FACS, for over five years. In 2018, the concept of Tribeca Aesthetics was a mere dream. Within three years, however, Dr. Sung had acquired premium property in strategically located lower Manhattan, converted it into fully certified first-class medical space (including a surgical suite), and built a thriving evidence-based plastic surgery and aesthetic practice.